Exonhit Announces New Scientific Publications on the Use of SpliceArray™
Complete the form below to unlock access to ALL audio articles.
ExonHit Therapeutics S.A. announces the publication of five new key scientific articles based on the use of its owned designed microarrays, SpliceArray™.
“We are excited that the use of ExonHit's microarrays (SpliceArray™ family of products) manufactured on the Agilent Technologies’ and Affymetrix’s microarray platforms, plays an intergral role in these scientific publications. These publications underline the relevance of ExonHit’s approach”, declared Loic Maurel, C.E.O of ExonHit.
“SpliceArray™ can be considered a new standard and a remarkable discovery tool which represents the most complete method to measure the expression of the Human transcriptome, and more recently the Rat transcriptome, in all their diversity. These tools are used by major academic research centers in Europe and the USA as well as by many of the top-tier pharmaceutical and biotechnology companies worldwide. Additionally, ExonHit remains the largest user of these microarrays, particularly within our internal molecular diagnostic discovery programs.”
